Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на этот ресурс: http://dspace.nuph.edu.ua/handle/123456789/34236
Полная запись метаданных
Поле DCЗначениеЯзык
dc.contributor.authorKrasovska, N.-
dc.contributor.authorBerest, G.-
dc.contributor.authorBelenichev, I.-
dc.contributor.authorSeverina, H.-
dc.contributor.authorNosulenko, I.-
dc.contributor.authorVoskoboinik, O.-
dc.contributor.authorOkovytyy, S.-
dc.contributor.authorKovalenko, S.-
dc.contributor.authorКрасовська, Н.-
dc.contributor.authorБерест, Ж.-
dc.contributor.authorБеленіщев, І.-
dc.contributor.authorСеверіна, Г.-
dc.contributor.authorНозуленко, І.-
dc.contributor.authorВоскобойнік, О.-
dc.contributor.authorОковітій, С.-
dc.contributor.authorКоваленко, С.-
dc.date.accessioned2025-01-23T12:53:13Z-
dc.date.available2025-01-23T12:53:13Z-
dc.date.issued2024-01-11-
dc.identifier.citation1-Heterocyclization as preparative approach for carboxy-containing triazolo[1,5-c]quinazolines with anti-inflammatory activity / N. Krasovska [et al.] // European Journal of Medicinal Chemistry. - 2024. - Vol. 266. - P. 116137. https://doi.org/10.1016/j.ejmech.2024.116137 Scopus, Web of Science, Q1uk_UA
dc.identifier.urihttp://dspace.nuph.edu.ua/handle/123456789/34236-
dc.description.abstractPresent article is devoted to the purposeful search of novel anti-inflammatory agents among carboxylcontaining partially hydrogenated [1,2,4]triazolo[1,5-с]quinazolines and products of their tandem cyclization. It has been shown that target compound's could be obtained via interaction between [2-(3- R-1H-1,2,4-triazol-5-yl)phenyl]amines and oxo-containing carboxylic acids and their esters of various structure. The structures of synthesized compounds were verified by appropriate methods, the features of NMR-spectra patterns were discussed as well. The low predicted toxicity of obtained compounds has been estimated using in silico methods. In vivo study on the model of acute aseptic inflammation (carrageenan test) have been revealed that synthesized compounds expose antiinflammatory activity in the range of 0.94-52.66%. 4-(2-(Ethoxycarbonyl)-5,6-dihydro- [1,2,4]triazolo[1,5-c]quinazolin-5-yl)benzoic acid has been identified as most active compound. Additionally, the effects of some (2-R-5,6-dihydro[1,2,4]triazolo[1,5-c]quinazolin-5-yl)benzoic acids (compounds 3) on the levels of key inflammatory markers have been estimated. It has been shown that studied compounds decrease the level of neutrophils, COX-2, nitrotyrosine, IL-1b, C-reactive protein and increase level of eNOS. 4-(2-(Ethoxycarbonyl)-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-5- yl)benzoic acid (3.2) has been identified as compound with most expressed anti-inflammatory activity and significant effect on the levels of marker of inflammatory processes. Molecular docking study towards СОХ-1 and СОХ-2 has been conducted to substantiate possible mechanism of obtained compounds anti-inflammatory activity. It has been found that fixation of 4-(2-(ethoxycarbonyl)-5,6- dihydro-[1,2,4]triazolo[1,5-c]quinazolin-5-yl)benzoic acid (3.2) molecule in active site of enzyme is outstandingly similar to the reference ligands. The essential value of carboxylic group for presence of anti-inflammatory activity has been estimated as result of SAR-analysis. It has been found that studied class of compounds is perspective for further structural modification aimed to the creation of novel anti-inflammatory agents.uk_UA
dc.language.isoenuk_UA
dc.subject1-heterocyclizationuk_UA
dc.subjectAnti-inflammatory activityuk_UA
dc.subjectCarboxy-containing triazolo[1,5- c]quinazolinesuk_UA
dc.subjectInflammation markersuk_UA
dc.subjectMolecular dockinguk_UA
dc.subjectPredicted toxicityuk_UA
dc.subjectSAR-analysisuk_UA
dc.subject[2-(3-R-1H- 1,2,4-triazol-5-yl)phenyl]aminesuk_UA
dc.title1-Heterocyclization as preparative approach for carboxy-containing triazolo[1,5-c]quinazolines with anti-inflammatory activityuk_UA
dc.typeArticleuk_UA
Располагается в коллекциях:Наукові публікації кафедри фармацевтичної хімії

Файлы этого ресурса:
Файл Описание РазмерФормат 
pubmed_ncbi.nlm.nih_5+1-Heterocyclization as preparative approach for.pdf156,82 kBAdobe PDFПросмотреть/Открыть


Все ресурсы в архиве электронных ресурсов защищены авторским правом, все права сохранены.